Table 1 Baseline characteristics of the study population
| Â | Control (43) | IR (52) | P |
|---|---|---|---|
Age (years) | 62.76 ± 10.82 | 62.50 ± 13.80 | 0.918 |
Sex (male), n (%) | 32 (74.42%) | 45 (86.54%) | 0.134 |
Body-mass index (kg/m2) | 23.90 ± 3.11 | 23.98 ± 2.77 | 0.889 |
Hypertension, n (%) | 24 (55.81%) | 30 (57.69%) | 0.854 |
Diabetes, n (%) | 5 (11.63%) | 15(28.84%) | 0.040 |
Smoking history, n (%) | 9 (20.93%) | 15 (28.84%) | 0.377 |
Hyperlipidemia, n (%) | 12 (27.91%) | 9 (17.31%) | 0.215 |
Heart rate (bpm) | 69.14 ± 11.99 | 76.22 ± 9.48 | 0.012 |
Systolic pressure (mmHg) | 134.95 ± 17.84 | 121.06 ± 16.96 | 0.185 |
ALT, U/L | 18.67 ± 10.122 | 41.42 ± 28.72 | 0.000 |
AST, U/L | 21.47 ± 9.91 | 172.42 ± 200.99 | 0.000 |
eGFR (ml/min) | 94.15 ± 13.52 | 92.20 ± 18.96 | 0.150 |
Triglycerides (mmol/L) | 1.93 ± 1.43 | 2.21 ± 2.70 | 0.481 |
Low-density lipoprotein (mmol/L) | 2.71 ± 0.74 | 2.76 ± 0.88 | 0.466 |
Albumin(g/L) | 41.40 ± 3.21 | 39.31 ± 3.93 | 0.006 |
Echocardiography measurements | Â | Â | Â |
LAD, mm | 39.26 ± 4.23 | 38.83 ± 4.81 | 0.649 |
LVEF, % | 62.79 ± 4.29 | 57.39 ± 8.10 | 0.000 |
White blood cells on admission†|  |  |  |
Total white blood cells, 109/L | 6.54 ± 5.43 | 12.97 ± 16.86 | 0.018 |
Neutrophils, % | 62.26 ± 9.65 | 75.61 ± 11.07 | 0.000 |
Lymphocytes, % | 27.50 ± 8.37 | 17.50 ± 9.89 | 0.000 |
Monocytes, % | 7.09 ± 3.99 | 5.73 ± 1.91 | 0.003 |
CRP, mg/L | 6.20 ± 17.34 | 22.24 ± 32.32 | 0.003 |